ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 52 filers reported holding ODONATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 37.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $17,236,000 | -61.8% | 12,767,435 | -17.7% | 3.47% | -63.0% |
Q3 2021 | $45,147,000 | -16.6% | 15,514,566 | 0.0% | 9.37% | -13.0% |
Q2 2021 | $54,146,000 | +2.0% | 15,514,566 | 0.0% | 10.78% | -27.8% |
Q1 2021 | $53,060,000 | -82.2% | 15,514,566 | 0.0% | 14.93% | -67.2% |
Q4 2020 | $297,880,000 | +45.6% | 15,514,566 | +1.8% | 45.48% | +22.8% |
Q3 2020 | $204,657,000 | -65.7% | 15,238,782 | +8.3% | 37.03% | -36.1% |
Q2 2020 | $595,947,000 | +53.4% | 14,075,269 | 0.0% | 57.94% | +6.2% |
Q1 2020 | $388,618,000 | -14.9% | 14,075,269 | 0.0% | 54.57% | -0.0% |
Q4 2019 | $456,742,000 | +24.7% | 14,075,269 | 0.0% | 54.57% | -12.9% |
Q3 2019 | $366,379,000 | -29.1% | 14,075,269 | 0.0% | 62.68% | -10.2% |
Q2 2019 | $516,422,000 | +78.5% | 14,075,269 | +7.6% | 69.79% | +30.9% |
Q1 2019 | $289,332,000 | +46.3% | 13,086,038 | -6.8% | 53.31% | +17.5% |
Q4 2018 | $197,785,000 | -26.1% | 14,047,250 | +1.8% | 45.38% | +3.8% |
Q3 2018 | $267,795,000 | -2.3% | 13,796,747 | +11.2% | 43.72% | +25.9% |
Q2 2018 | $274,064,000 | +4.2% | 12,412,338 | 0.0% | 34.74% | -10.1% |
Q1 2018 | $262,893,000 | -13.8% | 12,412,338 | +1.7% | 38.64% | -20.1% |
Q4 2017 | $305,058,000 | – | 12,202,338 | – | 48.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $297,880,000 | 45.48% |
Boxer Capital, LLC | 5,607,086 | $107,656,000 | 3.46% |
Samsara BioCapital, LLC | 815,421 | $15,656,000 | 1.57% |
GSA CAPITAL PARTNERS LLP | 148,148 | $2,844,000 | 0.46% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,211,728 | $23,265,000 | 0.38% |
RTW INVESTMENTS, LP | 1,000,139 | $19,203,000 | 0.32% |
Sio Capital Management, LLC | 75,500 | $1,450,000 | 0.30% |
AlphaCentric Advisors LLC | 29,594 | $568,000 | 0.24% |
Birchview Capital, LP | 20,000 | $384,000 | 0.22% |
Aristides Capital LLC | 33,226 | $638,000 | 0.22% |